Multicenter Retrospective Analysis of Pulmonary Sarcomatoid Carcinoma Clinically Diagnosed Using Small Biopsy Specimens
Pulmonary sarcomatoid carcinoma diagnosed based on small biopsy specimens is refractory to platinum-doublet chemotherapy, and immune checkpoint inhibitor therapy may improve the prognosis.
Authors
- Nozomu Murayama
- Zenta Seto
- Kenji Azechi
- Ryuji Hayashi (ORCID: https://orcid.org/0000-0002-4205-9540)
- Seisuke Okazawa (ORCID: https://orcid.org/0000-0002-2592-7131)
- Hirokazu Taniguchi (ORCID: https://orcid.org/0000-0003-2414-8344)
- Tomomi Ichikawa (ORCID: https://orcid.org/0000-0002-3998-0216)
- Yasuaki Masaki (ORCID: https://orcid.org/0000-0001-7001-9725)
- Minehiko Inomata (ORCID: https://orcid.org/0000-0002-6846-187X)
- Isami Mizushima
- Naoki Takata (ORCID: https://orcid.org/0000-0002-8479-8165)
- Takeshi Tsuda (ORCID: https://orcid.org/0000-0002-6243-4459)
- Masahiro Matsumoto
- Kotaro Tokui
- Toshiro Miwa
- Shingo Imanishi
Institutions
- Toyama Prefectural Central Hospital (JP)
- Toyama University Hospital (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-05-03
- DOI
- https://doi.org/10.21873/cdp.10448
- Citations
- 1
- Primary Topic
- Metastasis and carcinoma case studies
- Type
- article
- Field-Weighted Citation Impact
- 1.52